Skip to main content
Market intelligence
PBLSSector not reported

Parabilis Medicines, Inc. insider activity

In the last 90 days, 15 corporate insiders purchased $2,244,196,331 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$2,244,196,331
Corporate buyers
15
Latest transaction
Jul 22, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jul 22, 2026Ra Capital Healthcare Fund LpCorporate insiderOpen Market Purchase244,593$28.29$6,919,560
Jul 22, 2026Ra Capital Management L.p.Director / 10% OwnerOpen Market Purchase244,593$28.29$6,919,560
Jul 22, 2026Peter KolchinskyCorporate insiderOpen Market Purchase244,593$28.29$6,919,560